POLYCYTHEMIA VERA
Clinical trials for POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo for advanced blood cancer hits snag: trial ends early
Disease control TerminatedThis study looked at combining two drugs, ruxolitinib and CPX-351, to treat advanced stages of myeloproliferative neoplasms (MPN), a group of blood cancers. The goal was to find the best dose and see if the combo worked better than standard care for patients whose disease had pro…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE1, PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
AI predicts drug failure in rare blood cancer study
Knowledge-focused TerminatedThis study aimed to confirm if two simple blood test results—hemoglobin below 15.5 g/dL and a high red blood cell distribution width—could predict which patients with polycythemia vera would not respond well to the drug hydroxyurea. Researchers planned to follow 76 adults startin…
Matched conditions: POLYCYTHEMIA VERA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 11:18 UTC